Clinical trial
PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
NCT03166085
Study timeline
Study start (actual)2017-05-23Date precision: day
Registry last updated2021-12-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Interventions
PU-H71DRUG
Nab-paclitaxelDRUG
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Samus Therapeutics, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03166085 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.